Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans

Endocrinology (United States)

Volumn 156, Issue 3, 2015, Pages 1181-1193

  Lee, Min Hee ^a   Lee, Jung Uee ^b   Joung, Kyong Hye ^a   Kim, Yong Kyung ^a   Ryu, Min Jeong ^a   Lee, Seong Eun ^a   Kim, Soung Jung ^a   Chung, Hyo Kyun ^a   Choi, Min Jeong ^a   Chang, Joon Young ^a   Lee, Sang Hee ^c   Kweon, Gi Ryang ^a   Kim, Hyun Jin ^a   Kim, Koon Soon ^a   Kim, Seong Min ^a   Jo, Young Suk ^a   Park, Jeongwon ^d   Cheng, Sheue Yann ^d   Shong, Minho ^a  

^a Chungnam National University   (South Korea)

^b Daejeon St Mary's Hospital   (South Korea)

^c Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CD31 ANTIGEN; CHOLESTEROL; FAT DROPLET; FATTY ACID SYNTHASE; LIOTHYRONINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; SODIUM IODIDE SYMPORTER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; THYROGLOBULIN; THYROID PEROXIDASE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE; FAT INTAKE; LIPID;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; BROWN ADIPOSE TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENDOPLASMIC RETICULUM; FREE THYROXINE INDEX; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHYROIDISM; INTRACELLULAR SPACE; LIOTHYRONINE BLOOD LEVEL; LIPID STORAGE; LIPOGENESIS; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; STEATOSIS; THYROID DISEASE; THYROID FOLLICLE CELL; THYROID FOLLICULAR CELL STEATOSIS; THYROID WEIGHT; THYROTROPIN BLOOD LEVEL; THYROTROPIN RELEASE; THYROXINE BLOOD LEVEL; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; CYTOLOGY; FAT INTAKE; METABOLISM; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; PATHOLOGY; THYROID GLAND;

ADIPOSE TISSUE; ANIMALS; DIETARY FATS; HUMANS; HYPOTHYROIDISM; LIPIDS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, OBESE; OBESITY; THYROID GLAND;

EID: 84923870641     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1670     Document Type: Article

References (44)

1. Singer SJ, Nicolson GL. The fluid mosaic model of the structure of cell membranes. Science. 1972;175(4023):720-731.
2. Chen X, Iqbal N, Boden G. The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. J Clin Invest. 1999;103(3):365-372.
3. Unger RH. Lipid overload and overflow: Metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab. 2003;14(9):398-403.
4. Yang H, Galea A, Sytnyk V, Crossley M. Controlling the size of lipid droplets: Lipid and protein factors. Curr Opin Cell Biol. 2012;24(4):509-516.
5. So JS, Hur KY, Tarrio M, et al. Silencing of lipid metabolism genes through IRE1α-mediated mRNA decay lowers plasma lipids in mice. Cell Metab. 2012;16(4):487-499.
6. Li JZ, Ye J, Xue B, et al. Cideb regulates diet-induced obesity, liver steatosis, and insulin sensitivity by controlling lipogenesis and fatty acid oxidation. Diabetes. 2007;56(10):2523-2532.
7. Unger RH. Lipotoxic diseases. Annu Rev Med. 2002;53:319-336.
8. Thvilum M, Brandt F, Brix TH, Hegedüs L. A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol. 2012;8(7):417-424.
9. Reinehr T. Obesity and thyroid function. Mol Cell Endocrinol. 2010;316(2):165-171.
10. Bjorntorp P. Endocrine abnormalities of obesity. Metabolism. 1995; 44(9 Suppl 3):21-23.
11. Asvold BO, Bjøro T, Vatten LJ. Association of serumTSHwith high body mass differs between smokers and never-smokers. J Clin Endocrinol Metab. 2009;94(12):5023-5027.
12. Kok P, Roelfsema F, Langendonk JG, et al. High circulating thyrotropin levels in obese women are reduced after body weight loss induced by caloric restriction. J Clin Endocrinol Metab. 2005;90(8):4659-4663.
13. Szczepaniak LS, Victor RG, Mathur R, et al. Pancreatic steatosis and its relationship to β-cell dysfunction in humans: Racial and ethnic variations. Diabetes Care. 2012;35(11):2377-2383.
14. Montanya E, Nacher V, Biarnés M, Soler J. Linear correlation between beta-cell mass and body weight throughout the lifespan in Lewis rats: Role of beta-cell hyperplasia and hypertrophy. Diabetes. 2000;49(8):1341-1346.
15. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes. Proc Natl Acad Sci U S A. 1998;95(5):2498-2502.
16. van der Zijl NJ, Goossens GH, Moors CC, et al. Ectopic fat storage in the pancreas, liver, and abdominal fat depots: Impact on β-cell function in individuals with impaired glucose metabolism. J Clin Endocrinol Metab. 2011;96(2):459-467.
17. Prentki M, Nolan CJ. Islet beta cell failure in type 2 diabetes. J Clin Invest. 2006;116(7):1802-1812.
18. Di Scioscio V, Loffreda V, Feraco P, et al. Diffuse lipomatosis of thyroid gland. J Clin Endocrinol Metab. 2008;93(1):8-9.
19. Huang GW, Li YX, Hu ZL. Primary myxoid liposarcoma of the thyroid gland. J Clin Pathol. 2009;62(11):1037-1038.
20. Soda G, Baiocchini A, Nardoni S, Bosco D, Melis M. Benign tumors of heterotopic tissue in the thyroid gland: A report of two cases of lipomatous lesions. J Exp Clin Cancer Res. 2000;19(2):245-248.
21. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444(7121):847-853.
22. Flier JS, Harris M, Hollenberg AN. Leptin, nutrition, and the thyroid: the why, the wherefore, and the wiring. J Clin Invest. 2000; 105(7):859-861.
23. Horton JD, Goldstein JL, Brown MS. SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125-1131.
24. Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 2011;13(4):376-388.
25. Cohen-Lehman J, Dahl P, Danzi S, Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol. 2010;6(1):34-41.
26. Matsusue K, Kusakabe T, Noguchi T, et al. Hepatic steatosis in leptin-deficient mice is promoted by the PPARgamma target gene Fsp27. Cell Metab. 2008;7(4):302-311.
27. Britton KA, Fox CS. Ectopic fat depots and cardiovascular disease. Circulation. 2011;124(24):e837-841.
28. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: Old questions and new insights. Science. 2011;332(6037):1519-1523.
29. Ulianich L, Garbi C, Treglia AS, et al. ER stress is associated with dedifferentiation and an epithelial-to-mesenchymal transition-like phenotype in PC Cl3 thyroid cells. J Cell Sci. 2008;121(Pt 4):477-486.
30. Ozcan U, Cao Q, Yilmaz E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695):457-461.
31. York DA, Otto W, Taylor TG. Thyroid status of obese (ob/ob) mice and its relationship to adipose tissue metabolism. Comp Biochem Physiol B. 1978;59(1):59-65.
32. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf). 2007;67(2):265-269.
33. Kaplan MM, Young JB. Abnormal thyroid hormone deiodination in tissues of ob/ob and db/db obese mice. Endocrinology. 1987;120(3):886-893.
34. Sahai A, Malladi P, Pan X, et al. Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: Role of short-form leptin receptors and osteopontin. AmJ Physiol Gastrointest Liver Physiol. 2004;287(5):G1035-1043.
35. Kohn LD, Kosugi S, Ban T, et al. Molecular basis for the autoreactivity against thyroid stimulating hormone receptor. Int Rev Immunol. 1992;9(2):135-165.
36. Lemaire K, Schuit F. Integrating insulin secretion and ER stress in pancreatic β-cells. Nat Cell Biol. 2012;14(10):979-981.
37. Tersey SA, Nishiki Y, Templin AT, et al. Islet β-cell endoplasmic reticulum stress precedes the onset of type 1 diabetes in the nonobese diabetic mouse model. Diabetes. 2012;61(4):818-827.
38. Kim PS, Arvan P. Hormonal regulation of thyroglobulin export from the endoplasmic reticulum of cultured thyrocytes. J Biol Chem. 1993;268(7):4873-4879.
39. van de Graaf SA, Ris-Stalpers C, Pauws E, Mendive FM, Targovnik HM, de Vijlder JJ. Up to date with human thyroglobulin. J Endocrinol. 2001;170(2):307-321.
40. Kim PS, Kwon OY, Arvan P. An endoplasmic reticulum storage disease causing congenital goiter with hypothyroidism. J Cell Biol. 1996;133(3):517-527.
41. Kim PS, Hossain SA, Park YN, Lee I, Yoo SE, Arvan P. A single amino acid change in the acetylcholinesterase-like domain of thyroglobulin causes congenital goiter with hypothyroidism in the cog/ cog mouse: A model of human endoplasmic reticulum storage diseases. Proc Natl Acad Sci U S A. 1998;95(17):9909-9913.
42. Watkins SM, Reifsnyder PR, Pan HJ, German JB, Leiter EH. Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone. J Lipid Res. 2002;43(11):1809-1817.
43. Tepmongkol S, Keelawat S, Honsawek S, Ruangvejvorachai P. Rosiglitazone effect on radioiodine uptake in thyroid carcinoma patients with high thyroglobulin but negative total body scan: A correlation with the expression of peroxisome proliferator-activated receptor-gamma. Thyroid. 2008;18(7):697-704.
44. Kebebew E, Lindsay S, Clark OH, Woeber KA, Hawkins R, Greenspan FS. Results of rosiglitazone therapy in patients with thyroglob-ulin-positive and radioiodine-negative advanced differentiated thyroid cancer. Thyroid. 2009;19(9):953-956.